Couples counseling to reduce drug use and HIV risk
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study tests a couple-focused counseling approach to help male couples reduce drug use and lower the risk of HIV. You and your partner would join sessions together to talk about safer choices and support each other.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You and your main partner must both be cisgender men and have been together for at least 3 months.
- You must be between 18 and 55 years old. Your partner must be 18 or older.
- One of you must be HIV-negative (confirmed by a quick test).
- One of you must have used at least one drug (like cocaine, prescription pills not as directed, ecstasy, or poppers) in the past month.
- You must have had condomless anal sex in the past month with a casual partner, or with a partner whose HIV status is different, or with a non-monogamous partner.
- You must live in the United States and speak English well enough to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether repeating HIV testing once a year for male couples at higher risk helps results stay on track over time. It includes couples who previously took part in an earlier study and are willing to keep participating.
This study looks at how to better support young men living with or at risk for HIV while also addressing substance use. You'll work with a care team that helps you stay healthy and connected to services.
This study looks at using social connections to help people who inject drugs get HIV prevention and substance use support. The trial tests a program in Los Angeles that works with friends or peers to encourage PrEP (HIV prevention pills) and addiction treatment.
This study tests if a program that encourages positive activities (behavioral activation) can help people with HIV or on PrEP who also use substances improve their health. It focuses on those receiving long-acting injectable medications for HIV prevention or treatment.
This study tests how well a program combining telemedicine (virtual doctor visits) and peer support can help prevent HIV among people who inject drugs. You'd get trained, attend weekly group sessions, and invite a friend or partner to also take part.
This study tests whether a telehealth program can reduce harm and lower HIV risk by helping with safer syringe use. It may help if you have recent syringe exchange use and are not currently on HIV prevention pills.
Hear when a new Substance Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.